LYOPHILISIERTES DABIGATRAN

European patent · EP2391893 · In force

Register entry

Publication number
EP2391893
Application number
EP10701670
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 27, 2010
Published
Dec 7, 2011
Granted
Sep 3, 2014
Protection ends at the latest
Jan 26, 2030
Next annual fee due
Jan 31, 2027
IPC classes
A61K 9/19 (2006.01)
G01N 33/94 (2006.01)
G01N 33/96 (2006.01)
Priority
EP 09151865 02.02.2009
PCT application
PCT/EP2010/050925 27.01.2010
PCT publication
WO2010/086329 05.08.2010
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Sep 3, 2014

    Granted

    Published in Swissreg on 03.09.2014

Parties

Holder

Boehringer Ingelheim International GmbH

Binger Strasse 173, 55216 Ingelheim am Rhein, DE

Inventor

STANGIER, Joachim

55216 Ingelheim Am Rhein, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.